CT-P16
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CT-P16, covering 2019-07-25 to 2025-03-17. Get the full timeline:
Most recent: Clinical Trial Update: To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer [Phase 3]